Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3797-3801

  D'Alto, Michele ^a   Romeo, Emanuele ^b   Argiento, Paola ^b   Correra, Anna ^b   Santoro, Giuseppe ^b   Gaio, Gianpiero ^b   Sarubbi, Berardo ^b   Calabrò, Raffaele ^b   Russo, Maria Giovanna ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE

Author keywords

Congenital heart diseases; Hemodynamics; Pulmonary hypertension

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DEATH; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM DEFECT; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MALE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SHUNT CLOSURE; SHUNTING; SYSTEMIC VASCULAR RESISTANCE;

CONGENITAL HEART DISEASES; HEMODYNAMICS; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886288710     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.036     Document Type: Article

References (18)

1. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
2. R.L. van Loon, M.T. Roofthooft, and H.L. Hillege Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005 Circulation 124 2011 1755 1764
3. H. Baumgartner, P. Bonhoeffer, and N. De Groot ESC guidelines for the management of grown-up congenital heart disease (new version 2010) Eur Heart J 31 2010 2915 2957
4. P.L. Enright, and D.L. Sherrill Reference equations for the six-minute walk in healthy adults Am J Respir Crit Care Med 158 1998 1384 1387
5. G.H. Guyatt, M.J. Sullivan, and P.J. Thompson The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 1985 919 923
6. N. Galiè, M. Beghetti, and M.A. Gatzoulis Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
7. W. Grossman Clinical measurement of vascular resistance and assessment of vasodilator drugs W. Grossman, Cardiac catheterization and angiography 1991 Lea and Febiger Philadelphia, PA 143 151
8. M. Beghetti, N. Galiè, and D. Bonnet Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality? Congenit Heart Dis 7 2012 3 11
9. D.M. Smadja, P. Gaussem, and L. Mauge Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease Circulation 119 2009 374 381
10. C. O'Donnell, P.N. Ruygrok, K. Whyte, and N.J. Wilson Progressive pulmonary hypertension post atrial septal defect device closure-early symptomatic improvement may not predict outcome Heart Lung Circ 19 2010 713 716
11. K. Dimopoulos, A. Peset, and M.A. Gatzoulis Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy Int J Cardiol 129 2008 163 171
12. M. Schwerzmann, M. Zafar, P.R. McLaughlin, D.W. Chamberlain, G. Webb, and J. Granton Atrial septal defect closure in a patient with " irreversible" pulmonary hypertensive arteriopathy Int J Cardiol 110 2006 104 107
13. A.E. Frost, M.A. Quinones, W.A. Zoghbi, and G.P. Noon Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol J Heart Lung Transplant 24 2005 501 503
14. H. Yamauchi, S. Yamaki, M. Fujii, H. Iwaki, and S. Tanaka Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect Ann Thorac Surg 72 2001 905 906
15. K. Imanaka, Y. Kotsuka, S. Takamoto, A. Furuse, K. Inoue, and T. Shirai Atrial septal defect and severe pulmonary hypertension in an adult who needed nitric oxide inhalation after repair Kyobu Geka 51 1998 403 405
16. A. Eicken, G. Balling, H.P. Gildein, T. Genz, H. Kaemmerer, and J. Hess Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder Int J Cardiol 117 2007 e40 e42
17. P.M. Steele, V. Fuster, M. Cohen, D.G. Ritter, and D.C. McGoon Isolated atrial septal defect with pulmonary vascular obstructive disease - long-term follow-up and prediction of outcome after surgical correction Circulation 76 1987 1037 1042
18. S.G. Haworth, and A.A. Hislop Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006 Heart 95 2009 312 317